Singapore Markets close in 19 mins

Novo Nordisk A/S (0TDD.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
152.95+2.98 (+1.98%)
As of 07:16AM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 52.41B
Implied shares outstanding 6N/A
Float 81.61B
% held by insiders 10.01%
% held by institutions 18.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 39.10
Trailing annual dividend yield 36.07%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin 31.38%
Operating margin (ttm)42.73%

Management effectiveness

Return on assets (ttm)21.69%
Return on equity (ttm)72.00%

Income statement

Revenue (ttm)176.95B
Revenue per share (ttm)78.11
Quarterly revenue growth (yoy)25.50%
Gross profit (ttm)148.51B
EBITDA 80.93B
Net income avi to common (ttm)55.52B
Diluted EPS (ttm)2.92
Quarterly earnings growth (yoy)24.80%

Balance sheet

Total cash (mrq)23.57B
Total cash per share (mrq)10.48
Total debt (mrq)25.78B
Total debt/equity (mrq)30.88
Current ratio (mrq)0.89
Book value per share (mrq)27.38

Cash flow statement

Operating cash flow (ttm)78.89B
Levered free cash flow (ttm)57.5B